drugset / Trial / NCT03573622
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions
Timeline
- Start
- 2018-05-31
- Primary completion
- 2018-08-21
- Completion
- 2018-10-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarpogrelate | Small molecule | 300 mg | Oral |
Indications
No indication recorded.